The Current Ratio as of November 2024 (TTM) for Inventiva S.A. (IVA) is 0.95

According to Inventiva S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 0.95. This represents a change of -34.36% compared to the average of 1.45 of the last 4 quarters.

Inventiva S.A. (IVA) Historical Current Ratio (quarterly & annually)

How has IVA Current Ratio performed in the past?

The mean historical Current Ratio of Inventiva S.A. over the last ten years is 4.73. The current 0.95 Current Ratio has changed 1.91% with respect to the historical average. Over the past ten years (40 quarters), IVA's Current Ratio was at its highest in in the June 2017 quarter at 10.22. The Current Ratio was at its lowest in in the January 2013 quarter at 0.

Inventiva S.A. (IVA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Inventiva S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inventiva S.A. (IVA) Average Current Ratio

How has IVA Current Ratio performed in the past?

The current Current Ratio of Inventiva S.A. (IVA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Inventiva S.A. (IVA) Current Ratio vs. Peers

How is IVA’s Current Ratio compared to its peers?

Inventiva S.A.’s Current Ratio is less than Mineralys Therapeutics, Inc. (11.20), less than Eliem Therapeutics, Inc. (60.41), less than Anebulo Pharmaceuticals, Inc. (13.46), less than Janux Therapeutics, Inc. (57.34), less than Rezolute, Inc. (13.39), less than Monte Rosa Therapeutics, Inc. (6.56), less than NewAmsterdam Pharma Company N.V. (9.83), less than Cullinan Oncology, Inc. (28.87), less than Compass Therapeutics, Inc. (40.74), less than Arcellx, Inc. (6.01), less than Ventyx Biosciences, Inc. (14.19), less than Immunocore Holdings plc (5.17), less than Vaxcyte, Inc. (17.88), less than DICE Therapeutics, Inc. (25.88), less than Verrica Pharmaceuticals Inc. (2.36), less than LianBio (10.06), less than Edgewise Therapeutics, Inc. (30.24), less than Vigil Neuroscience, Inc. (8.39), less than Innate Pharma S.A. (2.92), greater than HCW Biologics Inc. (0.10), less than Inhibrx Biosciences, Inc. (6.20),

Build a custom stock screener for Inventiva S.A. (IVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inventiva S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inventiva S.A. (IVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inventiva S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.